CIN- L67120MH1995PLC084899
  

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Aarti Drugs Ltd.

NSE : AARTIDRUGSEQ BSE : 524348 ISIN CODE : INE767A01016Industry : Pharmaceuticals

News

  • Aarti Drugs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 10 Nov 2026 | 23:49 | Dion Global

    Transcript of Q2&H1 FY27 Earning Conference callmore...

  • Aarti Drugs - Analysts/Institutional Investor Meet/Con. Call Updates 10 Nov 2026 | 23:49 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Transcriptmore...
  • Aarti Drugs - Updates 06 Nov 2026 | 17:08 | Dion Global

    Aarti Drugs Limited has informed the Exchange regarding Inspection by USFDA of formulation facility of subsidiary Company Pinnacle Life Science Priva...more...

  • Aarti Drugs - Copy of Newspaper Publication 05 Nov 2026 | 19:14 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publicationmore...
  • Aarti Drugs - Analysts/Institutional Investor Meet/Con. Call Updates 04 Nov 2026 | 19:28 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Link of Audio Recording of Conference Call for Investor and Analystsmore...

  • Aarti Drugs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 04 Nov 2026 | 19:26 | Dion Global

    Audio recording for conference call for Analyst and Investorsmore...
  • Aarti Drugs - Investor Presentation 03 Nov 2026 | 22:19 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Investor Presentationmore...

  • Aarti Drugs - Press Release 03 Nov 2026 | 22:16 | Dion Global

    Aarti Drugs Limited has informed the Exchange regarding a press release dated November 03 2026 titled Q2&H1FY27 Business and Financial Performance .more...
  • Aarti Drugs - Announcement under Regulation 30 (LODR)-Investor Presentation 03 Nov 2026 | 21:47 | Dion Global

    Investor Presentation for Q2 FY27more...

  • Aarti Drugs - Announcement under Regulation 30 (LODR)-Press Release / Media Release 03 Nov 2026 | 21:17 | Dion Global

    Press release on Financial results for Quarter and Half year ended September 2026more...
  • Aarti Drugs Q2 net profit up 38.06% at Rs 57.68 cr 03 Nov 2026 | 20:40 | Dion Global

    The company reported standalone net profit of Rs 57.68 crore for the quarter ended September 30 2026 as compared to Rs 41.78 crore in the same period...more...

  • Aarti Drugs - Board Meeting Outcome for Financial Results For The Quarter And Half Year Ended September 30, 2026 03 Nov 2026 | 19:08 | Dion Global

    Financial Results for the quarter and half year ended September 30 2026more...
  • Aarti Drugs - Outcome of Board Meeting 03 Nov 2026 | 19:04 | Dion Global

    Aarti Drugs Limited has submitted to the Exchange the financial results for the period ended September 30 2026.more...

  • Aarti Drugs - Financial Results For The Quarter And Half Year Ended September 30, 2026 03 Nov 2026 | 19:04 | Dion Global

    Financial Results for the quarter and half year ended September 30 2026more...
  • Aarti Drugs - Analysts/Institutional Investor Meet/Con. Call Updates 28 Oct 2026 | 19:32 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Q2 H2 FY27 Earning Call Conference Intimationmore...

  • Aarti Drugs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 28 Oct 2026 | 19:27 | Dion Global

    Q2 H1 FY27 Earning Conference Call Intimationmore...
  • Aarti Drugs - Board Meeting Intimation for Audited Financial Results For The Quarter And Half Year Ended September 30, 2026 27 Oct 2026 | 20:56 | Dion Global

    Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and appro...more...

  • Aarti Drugs has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026 16 Oct 2026 | 22:40 | Dion Global

    As of September 2026 54.07% is owned by Indian Promoters and 45.93% by Public. Institutional holds 12.50% (Insurance Companies 0.08%) and No...more...
  • Aarti Drugs - General Updates 08 Oct 2026 | 19:22 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Crisil ESG Ratingmore...

  • Aarti Drugs - Crisil ESG Rating 08 Oct 2026 | 19:22 | Dion Global

    Intimation under Regulation 30 of SEBI LODR 2015 - Crisil ESG Ratingmore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
More

Sensex81911.010.99%
NSE Index25299.350.17%
B500DIVL503514.12-0.02%
BSE 1000 11162.561.33%
BSE 100LCTMC9475.160.95%
BSE Auto 62170.041.30%
More

Commodity


Gold137308-1.90%
Silver181073-2.62%
Copper1349.1230.82%
Crude Oil811726.57%
Lead196.346.06%
Mentha Oil1449.835.83%
Nickel1555102.76%
More

Currency


USD/INR93.8600 (-0.29%)
GBP/INR125.6100 (-0.61%)
EUR/INR104.7700 (-0.57%)
JPY/INR0.5900 (-1.03%)
CAD/INR66.4800 (-0.23%)
HKD/INR11.9700 (-0.31%)
More


Announcement Calendar

Previous monthNovember 2026Next month
MonTueWedThuFriSatSun
2627282930311
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
123456

Upcoming

BOARD MEETINGS
Company Name : Tirupati Fincorp
Date : 19-11-2026

More

Latest Videos

Watch More Videos